MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study

Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study

(2020) R. Velasco et al.   JOURNAL OF NEURO-ONCOLOGY

Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis

(2019) V. Rimelen et al.   Acta Neuropathologica Communications

STAT3 Activation Is Associated with Interleukin-10 Expression and Survival in Primary Central Nervous System Lymphoma

(2019) Xueliang Yang et al.   World Neurosurgery

MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA

(2018) Elisabetta Miserocchi et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases

(2018) J Seoane et al.   ANNALS OF ONCOLOGY

Phase Ib trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

(2018) Christian Grommes et al.   BLOOD

MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma

(2018) Laura S. Hiemcke-Jiwa et al.   BRITISH JOURNAL OF HAEMATOLOGY

The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid

(2017) Laura S. Hiemcke-Jiwa et al.   HEMATOLOGICAL ONCOLOGY

Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma

(2017) Maxime Fontanilles et al.   Oncotarget

The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients

(2016) Ludovic Nguyen-Them et al.   EUROPEAN JOURNAL OF CANCER

Primary central nervous system lymphoma

(2016) T. T. Batchelor   Hematology-American Society of Hematology Education Program

Expression of Tim-1 in primary CNS lymphoma

(2016) Wataru Kishimoto et al.   Cancer Medicine

Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma

(2016) Yang Song et al.   Scientific Reports

The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma

(2015) M.C. Mabray et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates

(2015) I. Bonzheim et al.   BLOOD

Recurrent mutations ofCD79BandMYD88are the hallmark of primary central nervous system lymphomas

(2015) T. Nakamura et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era

(2014) Andrés J. M. Ferreri et al.   BRITISH JOURNAL OF HAEMATOLOGY

Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system

(2014) Yasuo Sasagawa et al.   JOURNAL OF NEURO-ONCOLOGY

CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

(2013) J. L. Rubenstein et al.   BLOOD

Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis

(2013) Sylvain Fisson et al.   PLoS One

Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma

(2011) Manuel Montesinos-Rongen et al.   ACTA NEUROPATHOLOGICA

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

(2011) A. Baraniskin et al.   BLOOD

Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)

(2011) Takashi Sasayama et al.   NEURO-ONCOLOGY

CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients

(2009) L. Fischer et al.   CLINICAL CANCER RESEARCH